|
Biotech companies can maximise profits through effective IP management that is aligned with their market(s) and that fits their strategy. The most profitable market, the United States, should get top priority. But competitive advantage will soon be copied by competitors unless protected by the USPTO or maintained as a trade secret.
|
If your company is an Innovation Driven
Enterprise (IDE), ie a “tech company”, IP defines your business, determines your market and is
the foundation of your competitive advantage. It is also deeply
involved in developing your business model(s), planning your entry
into another country, generating new products and lines, and
estimating future revenues. A clear understanding of the relevant IP
is required for most decisions about licensing (licencing),
manufacturing, imports/exports,
collaborations and alliances. These reasons and more are why IP
management should be strategic.
|
Intellectual Property (IP) management is usually an afterthought in Small or Medium Enterprises (SMEs).
Reactive instead of proactive. Wishful instead of watchful. IP is usually poorly managed and rarely strategic, so it is not surprising
that it can waste money, miss opportunities and risk IP. |
|
Synapses has the knowledge, experience and connections to help you arrive, survive and thrive in the United States.
|